Biotricity Inc. (BTCY): Price and Financial Metrics

Biotricity Inc. (BTCY): $0.82

0.02 (-2.37%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

D

BTCY Price/Volume Stats

Current price $0.82 52-week high $3.75
Prev. close $0.84 52-week low $0.70
Day low $0.82 Volume 19,400
Day high $0.89 Avg. volume 77,610
50-day MA $0.98 Dividend yield N/A
200-day MA $1.16 Market Cap 17.84M

BTCY Stock Price Chart Interactive Chart >


Biotricity Inc. (BTCY) Company Bio


Biotricity, Inc. is a medical technology company, which is focused on biometric data monitoring solutions. It also involves in delivering, remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. The firm’s FDA-approved Bioflux MCT technology, is comprised of a monitoring device and software components, which is made available to the market, in order to assess, establish and develop sales processes, and market dynamics. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on August 29, 2012 and is headquartered in Redwood City, CA.


BTCY Latest News Stream


Event/Time News Detail
Loading, please wait...

BTCY Latest Social Stream


Loading social stream, please wait...

View Full BTCY Social Stream

Latest BTCY News From Around the Web

Below are the latest news stories about BIOTRICITY INC that investors may wish to consider to help them evaluate BTCY as an investment opportunity.

Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript

Biotricity, Inc. (NASDAQ:BTCY) Q2 2024 Earnings Call Transcript November 14, 2023 Operator: Good afternoon, and welcome to Biotricity’s Second Quarter Fiscal 2024 Financial Results and Business Update Conference Call. Today’s conference is being recorded. And at this time, I would like to turn the conference over to Debra Chen with Investor Relations. Please go ahead, […]

Yahoo | November 16, 2023

Biotricity Delivers Record Margins and Double Digit Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2024

Company reports Q2-FY24 revenue grew by 21.4% YOY to $2.9 million; continuing to advance toward positive cashflowRecurring technology fees, customer device sales, remain on an upward trendReduced SG&A to $3.5 million, down 22% compared to same period ...

Yahoo | November 14, 2023

Biotricity to Host Second Quarter Fiscal Year 2024 Financial Results and Business Update Call on November 14th

Biotricity improves margins while lowering selling expenses and operating lossesREDWOOD CITY, CA / ACCESSWIRE / November 10, 2023 / Biotricity Inc. (Nasdaq:BTCY) ("Biotricity" or the "Company"), a Technology-as-a-Service (TaaS) company operating in ...

Yahoo | November 10, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for another dive into the biggest pre-market stock movers as we break down all of the latest news for Tuesday morning.

William White on InvestorPlace | November 7, 2023

Biotricity Releases Another Groundbreaking Product: Biotres Pro

Company further expands its current product portfolio, making it the most comprehensive Remote Patient and Cardiac Monitoring portfolio globally.Company developed Biotres Pro with critical capability of cellular backup for connectivityRecently filed ...

Yahoo | October 31, 2023

Read More 'BTCY' Stories Here

BTCY Price Returns

1-mo -17.17%
3-mo -39.26%
6-mo -19.61%
1-year -72.20%
3-year -96.36%
5-year -74.69%
YTD -28.70%
2023 -57.22%
2022 -88.74%
2021 439.08%
2020 17.17%
2019 31.27%

Continue Researching BTCY

Want to see what other sources are saying about Biotricity Inc's financials and stock price? Try the links below:

Biotricity Inc (BTCY) Stock Price | Nasdaq
Biotricity Inc (BTCY) Stock Quote, History and News - Yahoo Finance
Biotricity Inc (BTCY) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!